Chemotherapy before and after gastric cancer surgery
Part of Cancer, Digestive system clinical trials.
This study looks back at patients with stomach cancer who received a combination of chemotherapy drugs (called FLOT) before and after surgery. It aims to see how well the treatment works and what side effects patients may have.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You were diagnosed with stomach or gastroesophageal junction cancer (stage I, II, or III), not stage IV (cancer that has spread).
- You received FLOT chemotherapy at Fundación Santa Fe de Bogotá between 2021 and 2025.
- Your cancer is adenocarcinoma, not other types like lymphoma or stromal tumors.
- You have enough medical records to track your treatment and outcomes.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a combination of chemotherapy drugs given before surgery for locally advanced stomach or gastroesophageal junction cancer. It aims to see if this approach helps shrink the tumor and improve outcomes.
This trial tests adding an immunotherapy drug (tislelizumab) to standard chemotherapy (FLOT) before surgery for people with stomach or esophagus cancer that can be removed but hasn't spread. The goal is to see if this combination is safe and works better than chemotherapy alone.
This trial compares two chemotherapy combinations given before surgery for stomach cancer that has not spread. The goal is to see which treatment works better and to shrink the tumor before removal.
This study looks for ways to predict whether neoadjuvant chemotherapy (chemo given before surgery) will work well in people with locally advanced stomach cancer. It may help doctors choose the best treatment plan sooner based on your test results.
This study looks at combining chemotherapy, immunotherapy, and a targeted drug called fruquintinib before surgery for people with stomach cancer that has spread. The goal is to see if this approach can shrink tumors and improve outcomes.
This Phase 1 trial tests how well a tailored (response-adapted) chemotherapy plan works before surgery for stomach or gastroesophageal junction cancer. It aims to improve treatment planning while checking early safety.
Hear when a new Gastric Adenocarcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.